Brief: Chromadex Corp Announced U.S. Ptab's Decision To Reject Thorne Research Attempt To Invalidate The 807 Patent

Niagen Bioscience

15/08/2022 11:39

Aug 15 (Reuters) - Chromadex Corp  CDXC.O :
    * CHROMADEX CORP - ANNOUNCED U.S. PTAB'S  DECISION TO REJECT
THORNE RESEARCH ATTEMPT TO INVALIDATE THE 807 PATENT
    * CHROMADEX CORP - CO HOLDS AN EXCLUSIVE LICENSE TO 807
PATENT FOR
COMPOSITIONS INCLUDING NICOTINAMIDE RIBOSIDE (NR) FROM TRUSTEES
OF DARTMOUTH COLLEGE

Source text for Eikon:  ID:nBw53xc7la 
Further company coverage:  CDXC.O 

 ((Reuters.Briefs@thomsonreuters.com;;))